This prospective, randomized, multicenter, open-label phase 2/3 trial assessed the effect of panretinal photocoagulation (PRP) plus intravitreal ranibizumab versus PRP alone in the treatment of ...

VANCOUVER -- Patients with proliferative diabetic retinopathy (PDR) had similar 5-year vision outcomes when treated with intravitreal ranibizumab (Lucentis) or panretinal photocoagulation (PRP), a ...

The American Society of Retina Specialists provided guidance on the management of nonproliferative and proliferative diabetic retinopathy without diabetic macular edema in an article in Journal of ...

Diabetic retinopathy (DR) is a leading cause of vision loss around the world, and remains the most common cause of blindness among working-age people in the United States and many developed countries.

Patients with proliferative diabetic retinopathy (PDR) exhibit marked visual dysfunction and structural changes in both the inner and outer retinal layers, research findings indicate. Overall visual ...

Platelet-rich plasma (PRP) therapy is a controversial treatment that uses a concentrated form of a person’s platelets to promote healing and regeneration in various tissues. PRP is becoming ...

We may earn commission from links on this page, but we only recommend products we love. Promise. By recommendation of board-certified plastic surgeon Jason B. Diamond, MD, FACS (he is the Hollywood ...